Möchten Sie immer auf dem neuesten Stand bleiben?

WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Siemens Healthineers, a leading global medical technology provider pioneering...

MMI (Medical Microinstruments, Inc.) today announced the commercial launch in the U.S. of its Robotic Suture.

Knoxville, TN, April 09, 2026 (GLOBE NEWSWIRE) -- LivTech, a leading provider of comprehensive healthcare tech solutions specifically designed for long-term post-acute care, today announced the...

Bethesda, MD, April 09, 2026 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) today announced that Ferring Pharmaceuticals and the Astellas/Pfizer Alliance will serve as National...

Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groupsAzenosertib...

Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of microplastics and nanoplastics (MNPs) in the human heart has been gaining attention in recent years. A study back in 2024...

BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the launch of bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL and...

Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trialsMeeting...

Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today...

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resistance and resensitize tumors to VEGFR TKI therapy Virtual investor call on April 17, 2026, at 7:30...